Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma

Post time 2024-4-25 20:52:33

journal：Gastroenterology

Authors：Chenhao Zhou; Jialei Weng; Chunxiao Liu; Shaoqing Liu; Zhiqiu Hu; Xiaoli Xie; Dongmei Gao; Qiang Zhou; Jialei Sun; Ruchen Xu; Hui Li; Yinghao Shen; Yong Yi; Yi Shi; Xia Sheng; Qiongzhu Dong; Mien-Chie Hung; Ning Ren

Published date：2023-6-

DOI：10.1053/j.gastro.2023.02.005

PDF link：https://www.sciencedirect.com/sc ... 016508523001373/pdf

Article link：http://dx.doi.org/10.1053/j.gastro.2023.02.005

Article Source：Elsevier BV。

Remark：

Post time 2024-4-25 20:52:34

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma